Fig. 6

Distribution of immunotherapy response makers across risk groups. A, B, C, and D The distribution of TMB, number of neoantigens and clonal neoantigens, as well as the number of subclonal neoantigens across risk groups. E The distribution of PD-L1 expression across risk groups. F and H The distribution of TIDE score, T-cell exclusion score, and T-cell dysfunction score across risk groups. *, **, and *** represent P < 0.05, P < 0.01, and P < 0.001, respectively